0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Sign in to save

Mitigation of polystyrene microplastic-induced hepatotoxicity in human hepatobiliary organoids through bile extraction

Ecotoxicology and Environmental Safety 2024 11 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 60 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Peilin Li, Daisuke Miyamoto, Tomohiko Adachi, Takanobu Hara, Akihiko Soyama, Hajime Matsushima, Hajime Imamura, Kengo Kanetaka, Weili Gu, Susumu Eguchi

Summary

Using lab-grown human liver organoids, researchers discovered that polystyrene microplastics accumulate in bile ducts and cause liver cell damage. They found that a bile acid medication called ursodeoxycholic acid actually helped move microplastics into bile ducts for removal, while blocking bile transport made the liver damage worse. This study suggests that the body's bile system may play a role in clearing microplastics from the liver, pointing toward potential treatment strategies.

Polymers
Body Systems

BACKGROUND & AIMS: Polystyrene microplastics (PS-MPs) are pervasive in our daily life and can be ingested by the human body through bioaccumulation, causing organ damage, especially liver damage. However, the effect of PS-MPs bioaccumulation on human hepatotoxicity and their metabolism remains unclear. Recent studies have demonstrated that PS-MPs cause lipid and bile acid metabolism disorders. The human hepatobiliary organoids (HBOs) regenerated from chemically induced liver progenitor cells converted by mature hepatocytes and the bile duct provides a bioengineering model for liver disease and hepatic metabolism. APPROACH & RESULTS: Exposure of HBOs to PS-MPs with a diameter of 1 µm for 48 h causes hepatotoxicity, hepatocyte damage, and changes in bile acid metabolism. PS-MPs could be accumulated into the bile ducts of HBOs, which can be promoted by ursodeoxycholic acid, increasing bile flow and volume by activating the bile transporter of BSEP in a dose-dependent manner along with MRP-2. The accumulation of PS-MPs in the bile duct was able to be inhibited by the bile transporter inhibitor of troglitazone that could inhibit the transporters of BSEP and MRP-2, which increased the hepatotoxicity caused by PS-MPs. CONCLUSIONS: This study provides insights into the metabolic pathways of PS-MPs in the liver and suggests potential therapeutic strategies to reduce MP-induced liver damage.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Polystyrene microplastics induce hepatotoxicity and disrupt lipid metabolism in the liver organoids

Using lab-grown human liver organoids, researchers showed that polystyrene microplastics caused liver cell damage even at concentrations found in the environment. The microplastics disrupted fat metabolism, increased harmful reactive oxygen species, and triggered inflammation in the liver tissue. This study provides early evidence that microplastic exposure could contribute to liver problems like fatty liver disease in humans.

Article Tier 2

Environmentally Relevant Concentrations of Microplastic Exposure Cause Cholestasis and Bile Acid Metabolism Dysregulation through a Gut-Liver Loop in Mice

Mice exposed to environmentally realistic levels of polystyrene microplastics for 30 days developed damaged intestinal barriers, liver injury, and disrupted bile acid metabolism. The study revealed a gut-liver feedback loop where microplastics alter gut bacteria, which changes bile acid production, which in turn causes further liver damage, suggesting a mechanism by which everyday microplastic exposure could harm digestive health.

Article Tier 2

Revealing transport, uptake and damage of polystyrene microplastics using a gut-liver-on-a-chip

Using an advanced gut-liver organ-on-a-chip system that mimics human digestion, researchers tracked how polystyrene microplastics travel from the intestine to the liver. The microplastics crossed the intestinal barrier, accumulated in liver tissue, and caused dose-dependent damage to liver cells. This human-relevant model provides strong evidence that microplastics ingested through food and water can reach and harm the liver.

Article Tier 2

Why do microplastics aggravate cholestatic liver disease? The NLRP3-mediated intestinal barrier integrity damage matter

Researchers used a mouse model to study how polystyrene microplastics affect cholestatic liver disease, a condition linked to disrupted bile flow. They found that microplastic exposure worsened liver damage by activating inflammatory pathways and breaking down the intestinal barrier, allowing harmful bacteria to reach the liver. The study suggests that microplastic ingestion may aggravate existing liver conditions through gut-liver interactions.

Article Tier 2

Combined effect of polystyrene microplastics and bisphenol A on the human embryonic stem cells-derived liver organoids: The hepatotoxicity and lipid accumulation

Researchers used human stem cell-derived liver organoids to study the combined toxic effects of polystyrene microplastics and the plasticizer bisphenol A. The study found that co-exposure produced enhanced hepatotoxicity and lipid accumulation compared to individual exposures, with changes in markers related to oxidative stress, inflammation, and energy metabolism in the liver tissue model.

Share this paper